$JNJ·8-K

JOHNSON & JOHNSON · Apr 14, 7:35 AM ET

Compare

JOHNSON & JOHNSON 8-K

Research Summary

AI-generated summary

Updated

Johnson & Johnson Reports Q1 2026 Results; Raises Dividend 3.1%

What Happened
Johnson & Johnson filed a Form 8-K on April 14, 2026 announcing its sales and earnings for the first quarter ended March 29, 2026 and disclosing that its Board approved a 3.1% increase in the quarterly dividend. The quarterly dividend was raised from $1.30 to $1.34 per share (annualized $5.36 vs. $5.20 previously). The 8-K includes a press release and unaudited condensed consolidated statement of earnings as exhibits.

Key Details

  • Filed April 14, 2026 for the quarter ended March 29, 2026; exhibits include the April 14 press release and supplementary financial data (Exhibits 99.1, 99.2).
  • Quarterly dividend increased 3.1% to $1.34 per share; annual indicated dividend $5.36 vs. prior $5.20.
  • Dividend payable June 9, 2026 to shareholders of record at close of business on May 26, 2026; ex-dividend date May 26, 2026.
  • Report signed by Robert J. Decker, Jr., Controller (Principal Accounting Officer).

Why It Matters
The filing provides the company’s latest quarterly results (sales and earnings) and confirms management’s decision to raise the dividend, extending a 64-year streak of annual increases. The dividend increase is a concrete return-of-capital signal for income-focused investors; the Q1 results (detailed in the attached press release and financial tables) give current information on revenue and profitability that investors should review when assessing JNJ’s near-term performance and income outlook.